Analysis of dynamic contrast enhanced MRI

British Journal of Radiology

Volumn 77, Issue SPEC. ISS. 2, 2004, Pages

  Jackson, A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CALCULATION; CONTRAST ENHANCEMENT; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; MATHEMATICAL COMPUTING; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; SIGNAL NOISE RATIO;

ALGORITHMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MODELS, CARDIOVASCULAR;

EID: 14044276970     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/16652509     Document Type: Article

References (50)

1. Barbier EL, Lamalle L, Decorps M. Methodology of brain perfusion imaging. J Magn Reson Imaging 2001;13:496-520.
2. Calamante F, et al. Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab 1999;19:701-35.
3. Ostergaard L, et al. Modelling cerebral blood flow and flow heterogeneity from magnetic resonance residue data. J Cereb Blood Flow Metab 1999;19:690-9.
4. Rosen BR, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991;19:285-92.
5. Sorensen A, Reimer P. Cerebral MR perfusion imaging: Principles and current applications. Stuttgart: Thieme, 2000:152.
6. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cerebral Blood Flow Metab 1998;18:1365-77.
7. Tofts PS, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-32.
8. Li KL, et al. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-57.
9. Keston P, Murray AD, Jackson A. Cerebral perfusion imaging using contrast-enhanced MRI. Clin Radiol 2003; 58:505-13.
10. Ostergaard L, et al. Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [O15] H2O positron emmission tomography in humans. J Cereb Blood Flow Metab 1998;18:935-40.
11. Rempp KA, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637-41.
12. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000; 44:466-73.
13. Boxerman JL, Rosen BR, Weisskoff RM. Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies. J Magn Reson Imaging 1997;7:528-37.
14. Li K, Zhu X, Jackson A. Scaled error mapping in MR perfusion imaging. In: Proceedings of the second conference on medical image understanding and analysis. Leeds. 1998.
15. Boxerman JL, et al. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995;34:555-66.
16. Sugahara T, et al. Perfusion-sensitive MR imaging of gliomas: comparison between gradient-echo and spin-echo echo-planar imaging techniques. AJNR Am J Neuroradiol 2001;22: 1306-15.
17. Kassner A, et al. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11: 103-13.
18. Aronen HJ, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41-51.
19. Thacker NA, Scott ML, Jackson A. Can dynamic susceptibility contrast magnetic resonance imaging perfusion data be analyzed using a model based on directional flow? J Magn Reson Imaging 2003;17:241-55.
20. Rosen BR, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990;14:249-65.
21. Davenport R. The derivation of gamma variat relationship for tracer dilution curves. J Nucl Med 1983;24:945-8.
22. Benner T, et al. Accuracy of gamma-variate fits to concentration-time curves from dynamic susceptibility-contrast enhanced MRI: influence of time resolution, maximal signal drop and signal-to-noise. Magn Reson Imaging 1997;15:307-17.
23. Belliveau JW, et al. Functional imaging by gamma analysis of contrast enhanced NMR. In: 8th Annual meeting of the Society of Magnetic Resonance in Medicine. 1989.
24. Maeda M, Maley JE, Crosby DL. Application of contrast agents in the evaluation of stroke: conventional MR and echo-planar MR imaging. J Magn Reson Med 1997;7: 723-8.
25. Kuhl CK, et al. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging [see comments]. Radiology 1997;202:87-95.
26. Miyati T, et al. Dual dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 1997;7:230-5.
27. Weisskoff RM, et al. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993;29:553-8.
28. Lythgoe DJ, et al. Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging. Magn Reson Imaging 2000;18:1-11.
29. 2* contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000;11:575-85.
30. Tofts PS, Kermode AG. Measurement of the blood brain barrier permeability and leakage space using dynamic MR imaging: fundemental concepts. Magn Reson Med 1991;17: 357-67.
31. Jayson GC, et al. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst 2002;94:1484-93.
32. Amoroso A, et al. Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review. Eur Rev Med Pharmacolog Sci 1997;1:17-25.
33. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29(6 Suppl 16):15-8.
34. Brasch R, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
35. Dvorak HF, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39.
36. Jensen RL. Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review. Surg Neurol 1998;49:189-95; discussion 196.
37. Stack J, Redmond O, Codd M, et al. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990;174:491-4.
38. Flickinger F, et al. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn Reson Imaging 1993;11:617-20.
39. Brix G, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comp Assist Tomog 1991; 15:621-8.
40. Knopp MV, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;10:260-6.
41. Knopp EA, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211: 791-8.
42. Hawighorst H, et al. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curve for assessment of tumor angiogenesis and patient survival. Cancer Res 1998;58:3598-602.
43. Parker GJ, et al. Improving image quality and T(1) measurements using saturation recovery turboFLASH with an approximate K-space normalisation filter. Magn Reson Imaging 2000;18:157-67.
44. Haroon HA, et al. A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas. J Magn Reson Imaging 2004;19: 527-36.
45. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
46. Jackson A, et al. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 2002;15:164-73.
47. Li KL, Jackson A. New hybrid technique for accurate and reproducible quantitation of dynamic contrast-enhanced MRI data. Magn Reson Med 2003;50:1286-95.
48. Li KL, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39-50.
49. Boxerman JL, et al. Signal to noise and tissue blood volume maps from dynamic NMR imaging studies. In: 11th annual meeting of the Society of Magnetic Resonance in Medicine. 1992.
50. Robson MD, Zhong J, Gore JC. Errors associated with fitting dynamic susceptibility contrast images for cerebral perfusion calculations. In: 13th annual conference of the Society of Magnetic Resonance in Medicine. 1994.